Oxycodone HCL-Acetaminophen Tablets
Awarded Award Notice Posted
- Solicitation number
- SPE2D221R0114
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Awarded
- to Specgx LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2D222D0150 Federal IDV award
- NAICS code
- 32541 Pharmaceutical and Medicine Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Hobart, New York 13788, United States
- Points of contact
-
- Courtney Hunter-Stangler courtney.hunter-stangler@dla.mil (215) 737-6845
- Jason Wray jason.wray@dla.mil (445) 737-6304
- Catherine Gilbert catherine.gilbert@dla.mil (445) 737-8868
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical awarded a contract to SpecGx LLC for Oxycodone HCL/Acetaminophen Tablets on September 29, 2022, under contract SPE2D2-22-D-0150, with a total value of $7,299,519.55.
The contract includes four option years. As of the most recent modification (P00009, signed September 2, 2026), Option Year 4 has been exercised, with performance running through September 28, 2027. The award was made under no set-aside. Place of performance is Webster Groves, Missouri (contractor location), with contract administration at DLA Troop Support Medical Supply Chain in Philadelphia, Pennsylvania.
The contract has been subject to multiple modifications incorporating regulatory and compliance updates: FAR 52.204-27 (ByteDance Covered Application prohibition), Drug Supply Chain Act language, FAR clause 52.222-90 (DEI Discrimination Discrimination, April 2026), and a mass modification based on Executive Orders 14173 and 14148 (effective April 22, 2025) that removed equal opportunity and environmental compliance provisions.
Notice text
6 versions
Update #6 · Latest ·
SPE2D2-22-D-0150 P00009 to invoke Option Year 4
SPE2D2-22-D-0150 P00008 - This modification hereby incorporates the attached bilateral agreement incorporating clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026).
SPE2D2-22-D-0150 P00007 to invoke Option Year 3
SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders.
SPE2D2-22-D-0150 P00005 to invoke Option Year 2
SPE2D2-22-D-0150 P00003 to invoke Option Year 1
SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract.
SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract.
Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.
Awarded contract SPE2D222D0150 to SPECGX LLC for 7299519.55 on 2022-09-29.
Update #5 ·
SPE2D2-22-D-0150 P00007 to invoke Option Year 3
SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders.
SPE2D2-22-D-0150 P00005 to invoke Option Year 2
SPE2D2-22-D-0150 P00003 to invoke Option Year 1
SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract.
SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract.
Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.
Awarded contract SPE2D222D0150 to SPECGX LLC for 7299519.55 on 2022-09-29.
Update #4 ·
SPE2D2-22-D-0150 P00005 to invoke Option Year 2
SPE2D2-22-D-0150 P00003 to invoke Option Year 1
SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract.
SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract.
Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.
Awarded contract SPE2D222D0150 to SPECGX LLC for 7299519.55 on 2022-09-29.
Update #3 ·
SPE2D2-22-D-0150 P00003 to invoke Option Year 1
SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract.
SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract.
Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.
Awarded contract SPE2D222D0150 to SPECGX LLC for 7299519.55 on 2022-09-29.
Update #2 ·
SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract.
SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract.
Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.
Awarded contract SPE2D222D0150 to SPECGX LLC for 7299519.55 on 2022-09-29.
Update #1 ·
Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.
Awarded contract SPE2D222D0150 to SpecGx LLC for 7299519.55 on 2022-09-29.
Attachments
| File | Type | Posted |
|---|---|---|
| SF30_SPE2D222D0150P00008.PDF | ||
| SF30_SPE2D222D0150P00009.PDF | ||
| SPE2D222D0150 MOD P00007 SIGNED.pdf | ||
| SF30_SPE2D222D0150P00006.PDF | ||
| Modification P00005 - Signed.PDF | ||
| SPE2D222D0150 P00003 Option Year 1.PDF | ||
| Signed SPE2D222D0150 P00002 Oxycodone HCL-Ace.pdf | ||
| SPE2D222D0150 P00001.pdf | ||
| Signed Oxycodone HCL-Acetaminophen Award SPE2D2-22-D-0150.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Oxycodone HCL-Acetaminophen Tablets | Award Notice | |
| Oxycodone HCL-Acetaminophen Tablets | Solicitation | |
| Oxycodone HCL-Acetaminophen Tablets | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity